David J. Caponera
Corporate Officer/Principal chez DICERNA PHARMACEUTICALS, INC.
Profil
David J.
Caponera is currently the Head of Patient Advocacy and Patient Services at Dicerna Pharmaceuticals, Inc. Previously, he worked as the VP of Patient Engagement and Access Support at Catalyst Pharmaceuticals, Inc. from 2014 to 2018.
He received his graduate degree from Duke University and his undergraduate degree from Cornell University.
Postes actifs de David J. Caponera
| Sociétés | Poste | Début |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13/06/2019 |
Anciens postes connus de David J. Caponera
| Sociétés | Poste | Fin |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2018 |
Formation de David J. Caponera
| Duke University | Graduate Degree |
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
